###begin article-title 0
###xml 23 50 23 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Schizosaccharomyces pombe. </italic>
###xml 79 81 79 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink">19</sup>
###xml 23 48 <span type="species:ncbi:4896">Schizosaccharomyces pombe</span>
Riboflavin synthase of Schizosaccharomyces pombe. Protein dynamics revealed by 19F NMR protein perturbation experiments
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 191 197 <span type="species:ncbi:4932">yeasts</span>
Riboflavin synthase catalyzes the transformation of 6,7-dimethyl-8-ribityllumazine into riboflavin in the last step of the riboflavin biosynthetic pathway. Gram-negative bacteria and certain yeasts are unable to incorporate riboflavin from the environment and are therefore absolutely dependent on endogenous synthesis of the vitamin. Riboflavin synthase is therefore a potential target for the development of antiinfective drugs.
###end p 2
###begin title 3
Results
###end title 3
###begin p 4
###xml 21 47 21 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Schizosaccharomyces pombe </italic>
###xml 134 151 134 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 182 190 182 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 615 618 609 612 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1 </sup>
###xml 621 624 615 618 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1 </sup>
###xml 642 644 636 638 <sub xmlns:xlink="http://www.w3.org/1999/xlink">M </sub>
###xml 659 661 653 655 <sup xmlns:xlink="http://www.w3.org/1999/xlink">19</sup>
###xml 846 848 840 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink">19</sup>
###xml 21 46 <span type="species:ncbi:4896">Schizosaccharomyces pombe</span>
###xml 134 150 <span type="species:ncbi:562">Escherichia coli</span>
###xml 182 189 <span type="species:ncbi:562">E. coli</span>
A cDNA sequence from Schizosaccharomyces pombe comprising a hypothetical open reading frame with similarity to riboflavin synthase of Escherichia coli was expressed in a recombinant E. coli strain. The recombinant protein is a homotrimer of 23 kDa subunits as shown by sedimentation equilibrium centrifugation. The protein sediments at an apparent velocity of 4.1 S at 20degreesC. The amino acid sequence is characterized by internal sequence similarity indicating two similar folding domains per subunit. The enzyme catalyzes the formation of riboflavin from 6,7-dimethyl-8-ribityllumazine at a rate of 158 nmol mg-1 min-1 with an apparent KM of 5.7 microM. 19F NMR protein perturbation experiments using fluorine-substituted intermediate analogs show multiple signals indicating that a given ligand can be bound in at least 4 different states. 19F NMR signals of enzyme-bound intermediate analogs were assigned to ligands bound by the N-terminal respectively C-terminal folding domain on basis of NMR studies with mutant proteins.
###end p 4
###begin title 5
Conclusion
###end title 5
###begin p 6
###xml 23 49 23 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Schizosaccharomyces pombe </italic>
###xml 352 353 352 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 355 356 355 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 379 381 379 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink">19</sup>
###xml 23 48 <span type="species:ncbi:4896">Schizosaccharomyces pombe</span>
Riboflavin synthase of Schizosaccharomyces pombe is a trimer of identical 23-kDa subunits. The primary structure is characterized by considerable similarity of the C-terminal and N-terminal parts. Riboflavin synthase catalyzes a mechanistically complex dismutation of 6,7-dimethyl-8-ribityllumazine affording riboflavin and 5-amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedione. The 19F NMR data suggest large scale dynamic mobility in the trimeric protein which may play an important role in the reaction mechanism.
###end p 6
###begin title 7
Background
###end title 7
###begin p 8
###xml 49 50 49 50 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 468 469 468 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 470 471 470 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 320 326 <span type="species:ncbi:4932">yeasts</span>
Flavocoenzymes derived from riboflavin (vitamin B2) act as cofactors for a variety of redox reactions and are indispensable in all cells. Whereas plants and many microorganisms obtain riboflavin by endogenous synthesis, animals depend on nutritional supply of the vitamin. Certain bacteria (e.g. Enterobacteriaceae) and yeasts are unable to incorporate riboflavin from the environment and are therefore absolutely dependent on the endogenous synthesis of the vitamin [1-4], and the enzymes of the riboflavin biosynthetic pathway are therefore potential targets for antiinfective drug design.
###end p 8
###begin p 9
###xml 308 309 308 309 <bold xmlns:xlink="http://www.w3.org/1999/xlink">3</bold>
###xml 316 317 316 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 350 351 350 351 <bold xmlns:xlink="http://www.w3.org/1999/xlink">4</bold>
###xml 385 386 385 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 388 389 388 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 417 418 417 418 <bold xmlns:xlink="http://www.w3.org/1999/xlink">1</bold>
###xml 556 557 556 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 558 559 558 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 683 684 683 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 685 687 685 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 753 754 753 754 <bold xmlns:xlink="http://www.w3.org/1999/xlink">5</bold>
###xml 761 762 761 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 858 860 858 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 891 908 891 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 912 930 912 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bacillus subtilis </italic>
###xml 957 959 957 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 960 962 960 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 58 63 <span type="species:ncbi:9606">human</span>
###xml 891 907 <span type="species:ncbi:562">Escherichia coli</span>
###xml 912 929 <span type="species:ncbi:1423">Bacillus subtilis</span>
The absence of the riboflavin biosynthetic pathway in the human host is advantageous with regard to drug development. The final step in the riboflavin biosynthetic pathway is catalyzed by riboflavin synthase. The mechanistically unusual dismutation of the substrate, 6,7-dimethyl-8-ribityllumazine (Compound 3, Fig. 1) affording riboflavin (Compound 4) and 5-amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedione (Compound 1) requires the presence of two substrate molecules serving as donor resp. acceptor of a 4-carbon moiety at the active site of the enzyme [5-7]. The regiochemistry of the enzyme-catalyzed reaction predicts an antiparallel arrangement of the two substrate molecules [8-10]. A pentacyclic dimer of 6,7-dimethyl-8-ribityllumazine (Compond 5, Fig. 2) has been identified as a kinetically competent intermediate in the complex reaction sequence [11]. The riboflavin synthases of Escherichia coli and Bacillus subtilis are homotrimeric proteins [12-14].
###end p 9
###begin p 10
###xml 0 62 0 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Terminal reactions in the pathway of riboflavin biosynthesis. </bold>
Terminal reactions in the pathway of riboflavin biosynthesis. A, 3,4-dihydroxy-2-butanone 4-phosphate synthase; B, 6,7-dimethyl-8-ribityllumazine synthase; C, riboflavin synthase.
###end p 10
###begin p 11
###xml 0 56 0 56 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Hypothetical reaction mechanism of riboflavin synthase. </bold>
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
Hypothetical reaction mechanism of riboflavin synthase. X, unkown nucleophile; R, ribityl. [11]
###end p 11
###begin p 12
###xml 325 327 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 372 380 372 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 558 560 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 655 663 655 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 372 379 <span type="species:ncbi:562">E. coli</span>
###xml 655 662 <span type="species:ncbi:562">E. coli</span>
Intramolecular sequence similarity suggested that each subunit folds into two topologically similar domains, each of which can accommodate one substrate molecule. The active site was proposed to be located at the interface of adjacent domains; two substrate molecules were assumed to be sandwiched between adjacent subunits [14]. The structure of riboflavin synthase from E. coli as determined by X-ray crystallography at a resolution of 2.0 A confirmed the predicted similarity in the folding patterns of the N-terminal and C-terminal domain (rms = 0.8 A) [15] but gave no direct information on enzyme substrate interaction. The N-terminal domain of the E. coli enzyme (residues 1 - 97) could be expressed as a stable protein with a relatively high affinity for riboflavin.
###end p 12
###begin p 13
###xml 44 46 44 46 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 315 317 315 317 <sup xmlns:xlink="http://www.w3.org/1999/xlink">19</sup>
###xml 481 483 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 484 486 484 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
Surprisingly, this artificial protein is a c2 symmetric homodimer, whereas the full length riboflavin synthase subunit forms a homotrimer [16]. The structure of the artificial N-terminal domain dimer in complex with riboflavin has been determined by NMR spectroscopy [17]. Protein perturbation studies monitored by 19F NMR with fluorine-substituted intermediate analogs had suggested that the binding sites of the homotrimeric riboflavin synthase are not topologically equivalent [18-20].
###end p 13
###begin p 14
###xml 262 264 262 264 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 437 445 437 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 493 502 493 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pombe </italic>
###xml 814 823 814 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pombe </italic>
###xml 827 835 827 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 998 1000 998 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1022 1024 1022 1024 <sup xmlns:xlink="http://www.w3.org/1999/xlink">19</sup>
###xml 1109 1118 1109 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pombe </italic>
###xml 437 444 <span type="species:ncbi:562">E. coli</span>
###xml 493 501 <span type="species:ncbi:4896">S. pombe</span>
###xml 814 822 <span type="species:ncbi:4896">S. pombe</span>
###xml 827 834 <span type="species:ncbi:562">E. coli</span>
###xml 1109 1117 <span type="species:ncbi:4896">S. pombe</span>
More specifically, these experiments showed that certain ligands could be bound to the protein in at least four different binding states, whereas only two different states (one for the N-terminal and one for the C-terminal domain) would have been expected in a c3 symmetric homotrimer. These observations are well in line with the absence of trigonal molecular symmetry revealed by the X-ray structure analysis of riboflavin synthase of E. coli [15]. The structure of riboflavin synthase from S. pombe in complex with the substrate analog, 6-carboxyethyl-7-oxo-8-ribityllumazine has been determined at 2.1 A resolution. In contrast to the homotrimeric solution state of native riboflavin synthase, the enzyme was found to be monomeric in the crystal structure. Structural comparison of the riboflavin synthases of S. pombe and E. coli suggested oligomer contact sites and delineated the catalytic site for dimerization of the substrate and subsequent fragmentation of the pentacyclic intermediate [21]. This paper reports 19F NMR protein perturbation studies using wild type and mutant riboflavin synthase of S. pombe in complex with fluorinated intermediate analogs. The data suggest large scale domain mobility which appear relevant for the complex reaction mechanism.
###end p 14
###begin title 15
Results
###end title 15
###begin p 16
###xml 11 15 11 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rib5</italic>
###xml 15 17 15 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 25 34 25 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pombe </italic>
###xml 195 209 195 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. cerevisiae </italic>
###xml 255 262 255 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 25 33 <span type="species:ncbi:4896">S. pombe</span>
###xml 195 208 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 255 262 <span type="species:ncbi:562">E. coli</span>
A putative rib5+ gene of S. pombe (NCBI accession number, T40995) predicted a protein of 208 amino acid residues with similarity to riboflavin synthase (50 % identity with riboflavin synthase of S. cerevisiae and 36 % identity with riboflavin synthase of E. coli).
###end p 16
###begin p 17
###xml 42 51 42 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pombe </italic>
###xml 42 50 <span type="species:ncbi:4896">S. pombe</span>
The open reading frame was amplified from S. pombe cDNA and was cloned into the plasmid vector pNCO113. The cDNA sequence as determined by dideoxynucleotide sequencing was identical with the chromosomal sequence reported earlier and has been deposited in the GenBank data base (accession number AF505789).
###end p 17
###begin p 18
###xml 14 22 14 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 57 70 57 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pombe rib5</italic>
###xml 70 72 70 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 109 113 109 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lac </italic>
###xml 14 21 <span type="species:ncbi:562">E. coli</span>
###xml 57 65 <span type="species:ncbi:4896">S. pombe</span>
A recombinant E. coli strain carrying a plasmid with the S. pombe rib5+ gene under control of the T5 and the lac operator expressed a protein with an approximate mass of 23 kDa as judged by SDS electrophoresis. The recombinant protein accounting for about 20 % of cell protein was purified to apparent homogeneity by three chromatographic steps as described under Methods. Partial Edman degradation afforded the N-terminal sequence MFTGLVEAIGVVKDVQGTID in agreement with the open reading frame.
###end p 18
###begin p 19
###xml 140 141 140 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
The protein shows internal sequence similarity. Twenty one amino acid residues are identical in the N-terminal and C-terminal section (Fig. 3).
###end p 19
###begin p 20
###xml 38 47 38 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pombe </italic>
###xml 0 68 0 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Intramolecular sequence similarity of <italic>S. pombe </italic>riboflavin synthase. </bold>
###xml 38 46 <span type="species:ncbi:4896">S. pombe</span>
Intramolecular sequence similarity of S. pombe riboflavin synthase. N-terminal part, amino acids 1-97; C-terminal part, amino acids 98-208. Identical residues are coloured black. The residues subjected to mutagenesis in this study are marked by an arrow.
###end p 20
###begin p 21
###xml 62 65 62 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1 </sup>
###xml 68 71 68 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1 </sup>
###xml 88 90 88 90 <sub xmlns:xlink="http://www.w3.org/1999/xlink">M </sub>
###xml 133 134 126 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 600 601 593 594 <bold xmlns:xlink="http://www.w3.org/1999/xlink">8</bold>
###xml 608 609 601 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 734 746 727 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. subtilis </italic>
###xml 750 758 743 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 759 761 752 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 762 764 755 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 734 745 <span type="species:ncbi:1423">B. subtilis</span>
###xml 750 757 <span type="species:ncbi:562">E. coli</span>
The recombinant protein had a specific activity of 158 nmol mg-1 min-1 and an apparent KM of 5.7 muM at pH 7.2 and 37degreesC (Table 1). Electrospray mass spectrometry afforded a relative mass of 22,863 Da in good agreement with the predicted mass of 22,861 Da. The recombinant protein sediments as a single, symmetrical boundary with an apparent velocity of 4.1 S. Sedimentation equilibrium experiments indicate a molecular mass of 74 kDa using an ideal monodisperse model for simulation. Sedimentation equilibrium analysis in the presence of 5 mM 6-carboxyethyl-7-oxo-8-D-ribityllumazine (Compound 8; Fig. 4) afforded an apparent molecular weight of 76 kDa. It follows that the enzyme is homotrimer like the riboflavin synthases of B. subtilis and E. coli [13,22] and that the quaternary structure is not affected by binding of the substrate analog.
###end p 21
###begin p 22
Bacterial strains and plasmids
###end p 22
###begin p 23
###xml 0 60 0 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Intermediate analogs used for protein perturbation studies. </bold>
###xml 131 133 131 133 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6a</bold>
###xml 158 160 158 160 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6b</bold>
###xml 215 216 215 216 <bold xmlns:xlink="http://www.w3.org/1999/xlink">7</bold>
###xml 268 269 268 269 <bold xmlns:xlink="http://www.w3.org/1999/xlink">8</bold>
###xml 300 301 300 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 303 304 303 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 332 333 332 333 <bold xmlns:xlink="http://www.w3.org/1999/xlink">9</bold>
Intermediate analogs used for protein perturbation studies. 6,7-bis(trifluoromethyl)-8-ribityllumazine hydrate, epimer A (Compound 6a) and epimer B (Compound 6b). 6-trifluoromethyl-7-oxo-8-ribityllumazine (Compound 7). 6-carboxyethyl-7-oxo-8-ribitylluamzine (Compound 8), 5-nitro-6-ribitylamino-2,4(1H,3H)-pyrimidinedione (Compound 9).
###end p 23
###begin p 24
###xml 42 44 42 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink">19</sup>
###xml 108 120 108 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. subtilis </italic>
###xml 124 132 124 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 316 317 316 317 <bold xmlns:xlink="http://www.w3.org/1999/xlink">7</bold>
###xml 324 325 324 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 407 409 407 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink">19</sup>
###xml 536 538 536 538 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6a</bold>
###xml 640 666 640 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Photobacterium phosphoreum</italic>
###xml 869 871 869 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 872 874 872 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 923 931 923 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 966 968 966 968 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 1091 1093 1091 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 108 119 <span type="species:ncbi:1423">B. subtilis</span>
###xml 124 131 <span type="species:ncbi:562">E. coli</span>
###xml 640 666 <span type="species:ncbi:659">Photobacterium phosphoreum</span>
###xml 923 930 <span type="species:ncbi:562">E. coli</span>
Protein perturbation studies monitored by 19F NMR had been performed earlier with riboflavin synthases from B. subtilis and E. coli and had shown surprising multiplicities of signals for enzyme-bound ligands [18-20,23]. Thus, studies with the intermediate analog, 6-trifluoromethyl-7-oxo-8-ribityllumazine (Compound 7, Fig. 4) had suggested at least four different binding states characterized by different 19F signals spread over a range of about 9 ppm, and the covalent hydrate of 6,7-bis(trifluoromethyl)-8-ribityllumazine (Compound 6a, epimer A) could be bound in at least two different states. On the other hand, lumazine protein from Photobacterium phosphoreum, a monomeric paralog of riboflavin synthase without enzyme activity which serves as an optical transponder in bioluminescence showed single signals for each trifluoromethyl group of lumazine analogues [24,25]. Similarly, an artificial N-terminal domain of E. coli riboflavin synthase which forms a c2 symmetric homodimer showed single lines for each trifluoromethyl group of trifluoromethylsubstituted lumazine derivatives [16].
###end p 24
###begin p 25
###xml 6 7 6 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 12 13 12 13 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 107 116 107 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pombe </italic>
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 191 199 191 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 301 309 301 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C,5D,5E</xref>
###xml 311 319 311 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C,6D,6E</xref>
###xml 107 115 <span type="species:ncbi:4896">S. pombe</span>
###xml 191 198 <span type="species:ncbi:562">E. coli</span>
Figs. 5 and 6 show comparative protein perturbation experiments with various orthologs and paralogs of the S. pombe enzyme including lumazine protein (Figs. 5A, 6A), the N-terminal domain of E. coli riboflavin synthase (Figs. 5B, 6B) and full length riboflavin synthases of different organisms (Figs. 5C,5D,5E, 6C,6D,6E). All spectra were recorded in the present study under identical experimental conditions.
###end p 25
###begin p 26
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">19</sup>
###xml 2 75 2 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F NMR spectra of 6-trifluoromethyl-7-oxo-8-ribityllumazine (Compound 7). </bold>
###xml 98 112 98 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. leiognathi </italic>
###xml 138 139 138 139 <bold xmlns:xlink="http://www.w3.org/1999/xlink">7</bold>
###xml 178 186 178 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 232 233 232 233 <bold xmlns:xlink="http://www.w3.org/1999/xlink">7</bold>
###xml 262 270 262 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 296 297 296 297 <bold xmlns:xlink="http://www.w3.org/1999/xlink">7</bold>
###xml 326 338 326 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. subtilis </italic>
###xml 364 365 364 365 <bold xmlns:xlink="http://www.w3.org/1999/xlink">7</bold>
###xml 394 403 394 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pombe </italic>
###xml 429 430 429 430 <bold xmlns:xlink="http://www.w3.org/1999/xlink">7</bold>
###xml 499 500 499 500 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 98 111 <span type="species:ncbi:553611">P. leiognathi</span>
###xml 178 185 <span type="species:ncbi:562">E. coli</span>
###xml 262 269 <span type="species:ncbi:562">E. coli</span>
###xml 326 337 <span type="species:ncbi:1423">B. subtilis</span>
###xml 394 402 <span type="species:ncbi:4896">S. pombe</span>
19F NMR spectra of 6-trifluoromethyl-7-oxo-8-ribityllumazine (Compound 7). A, lumazine protein of P. leiognathi (0.13 mM protein, 0.25 mM 7); B, recombinant N-terminal domain of E. coli riboflavin synthase (0.80 mM protein, 0.98 mM 7); C, riboflavin synthase of E. coli (0.37 mM protein, 1.43 mM 7); D, riboflavin synthase of B. subtilis (0.10 mM protein, 0.75 mM 7); E, riboflavin synthase of S. pombe (0.28 mM protein, 1.22 mM 7). All samples contained 20 mM phosphate buffer, 100 mM KCl and 10% D2O, pH 7. Signals of the free ligand are indicated by a dashed line. The data were processed with a line broadening of 20 Hz.
###end p 26
###begin p 27
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">19</sup>
###xml 2 81 2 81 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F NMR signals of 6,7-bis(trifluoromethyl)-8-ribityllumazine hydrate (epimer A; </bold>
###xml 81 95 81 95 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Compound 6a). </bold>
###xml 118 132 118 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. leiognathi </italic>
###xml 158 160 158 160 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6a</bold>
###xml 199 207 199 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 253 255 253 255 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6a</bold>
###xml 284 292 284 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 317 319 317 319 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6a</bold>
###xml 348 360 348 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. subtilis </italic>
###xml 386 388 386 388 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6a</bold>
###xml 417 426 417 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pombe </italic>
###xml 452 454 452 454 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6a</bold>
###xml 509 510 509 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 118 131 <span type="species:ncbi:553611">P. leiognathi</span>
###xml 199 206 <span type="species:ncbi:562">E. coli</span>
###xml 284 291 <span type="species:ncbi:562">E. coli</span>
###xml 348 359 <span type="species:ncbi:1423">B. subtilis</span>
###xml 417 425 <span type="species:ncbi:4896">S. pombe</span>
19F NMR signals of 6,7-bis(trifluoromethyl)-8-ribityllumazine hydrate (epimer A; Compound 6a). A, lumazine protein of P. leiognathi (0.14 mM protein, 0.23 mM 6a); B, recombinant N-terminal domain of E. coli riboflavin synthase (0.75 mM protein, 0.56 mM 6a); C, riboflavin synthase of E. coli (0.5 mM protein, 3.34 mM 6a); D, riboflavin synthase of B. subtilis (0.13 mM protein, 0.41 mM 6a); E, riboflavin synthase of S. pombe (0.26 mM protein, 0.60 mM 6a); x, impurities. For other details see legend to Fig. 5.
###end p 27
###begin p 28
###xml 45 46 45 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink">7</bold>
###xml 87 96 87 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pombe </italic>
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5E</xref>
###xml 245 246 245 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 432 440 432 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C</xref>
###xml 454 466 454 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. subtilis </italic>
###xml 472 474 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5D</xref>
###xml 618 620 618 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 631 633 631 633 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 665 673 665 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 699 701 699 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 976 978 976 978 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 87 95 <span type="species:ncbi:4896">S. pombe</span>
###xml 432 439 <span type="species:ncbi:562">E. coli</span>
###xml 454 465 <span type="species:ncbi:1423">B. subtilis</span>
###xml 665 672 <span type="species:ncbi:562">E. coli</span>
The monotrifluoromethyl derivative, Compound 7, in complex with riboflavin synthase of S. pombe shows four signals at 8.8, 10.9, 15.6 and 16.0 ppm (Fig. 5E). The signal of the free ligand resonates at 7.7 ppm (indicated by a dashed line in Fig. 5) with a line width of 56 Hz, whereas the signals of the ligand bound in different states had apparent line widths extending from 90 to approximately 540 Hz. The riboflavin synthases of E. coli (Fig. 5C) and B. subtilis (Fig. 5D) show similar signal multiplicities, but the chemical shifts and line widths are markedly different. In stark contrast, lumazine protein (Fig. 5A) and the c2 symmetric N-terminal domains of E. coli riboflavin synthase (Fig. 5B) show single and much narrower lines for the protein bound ligand. It is immediately obvious that a given ligand can be bound in multiple, significantly different states by all riboflavin synthases studied, but only in a single state by lumazine protein or the artificial, c2 symmetric N-terminal domain.
###end p 28
###begin p 29
###xml 64 67 64 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6a </bold>
###xml 119 120 119 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 230 233 230 233 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6a </bold>
###xml 237 240 237 240 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6b </bold>
###xml 399 400 399 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 453 455 453 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 456 458 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
A similar set of experiments with the bistrifluoromethyl analog 6a of 6,7-dimethyl-8-ribityl-lumazine is shown in Fig. 6. Due to the presence of six fluorine atoms, the lumazine derivative forms two stable diastereomeric hydrates 6a and 6b which differ by their configuration at the ring carbon atom 7 and are not subject to racemization or dehydration. The stereochemical assignments shown in Fig. 4 were suggested on basis of solid-state NMR studies [26,27].
###end p 29
###begin p 30
###xml 17 22 17 22 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A,6B</xref>
###xml 78 86 78 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 173 175 173 175 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6a</bold>
###xml 230 238 230 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C,6D,6E</xref>
###xml 365 374 365 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pombe </italic>
###xml 380 382 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6E</xref>
###xml 78 85 <span type="species:ncbi:562">E. coli</span>
###xml 365 373 <span type="species:ncbi:4896">S. pombe</span>
As shown in Fig. 6A,6B, lumazine protein and the dimeric N-terminal domain of E. coli riboflavin synthase show single lines for each trifluoromethyl group of bound Compound 6a. In contrast to that, the riboflavin synthases (Figs. 6C,6D,6E) studied show multiple signals, and the signal patterns are highly variable for enzymes from different species. The enzyme of S. pombe (Fig. 6E) shows the most complex picture with three major signals for the position 7 trifluoromethyl group and two major signals for the position 6 trifluoromethyl group of the ligand in the bound state. The signals of the free epimer A appeared broadened to 80 Hz - 100 Hz, whereas the signals of the ligand bound in different states had apparent line widths of 170 - 300 Hz.
###end p 30
###begin p 31
###xml 33 35 33 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">19</sup>
###xml 103 111 103 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 411 413 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 464 473 464 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pombe </italic>
###xml 527 535 527 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 561 570 561 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pombe </italic>
###xml 780 781 780 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 103 110 <span type="species:ncbi:562">E. coli</span>
###xml 464 472 <span type="species:ncbi:4896">S. pombe</span>
###xml 527 534 <span type="species:ncbi:562">E. coli</span>
###xml 561 569 <span type="species:ncbi:4896">S. pombe</span>
In an earlier study, we reported 19F protein perturbation studies obtained with a series of mutants of E. coli riboflavin synthase [18]. In that study, it was not possible to express mutant proteins characterized by replacement of the conserved cysteine 48 which is located close to the bound riboflavin in the artificial N-terminal domain dimer [17]. Since a catalytic role had been proposed for that residue [17], a renewed mutagenesis attempt was made with the S. pombe protein. In contrast to our earlier findings with the E. coli enzyme, cystein 48 of the S. pombe enzyme could be replaced by various amino acids, and the proteins could be expressed to high levels. Similarly, mutant proteins with the topologically equivalent S146 residue in the C-terminal domain (cf. Fig. 3) could be expressed.
###end p 31
###begin p 32
###xml 64 65 64 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 356 364 356 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 385 387 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 474 475 474 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 534 535 534 535 <bold xmlns:xlink="http://www.w3.org/1999/xlink">7</bold>
###xml 542 543 542 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 617 619 617 619 <sup xmlns:xlink="http://www.w3.org/1999/xlink">19</sup>
###xml 356 363 <span type="species:ncbi:562">E. coli</span>
The catalytic properties of the mutants are summarized in Table 3. Replacement of cystein 48 by serine reduced the catalytic rate of the enzyme by a factor of about 6; C48A and C48M mutants had no detectable enzyme activity. The replacement of serine 146 had only a minor influence on the catalytic rate, in close similarity with our earlier findings with E. coli riboflavin synthase [18]. The replacement of cystein 48 had major impact on ligand perturbation spectra (Fig. 7) with 6-trifluoromethyl-7-oxo-8-ribityllumazine (Compound 7, Fig. 4). When cystein was replaced by less bulky residues (alanine, serine), no 19F NMR signals were noted in the range of 14 - 17 ppm, whereas the wild type protein shows two intense, closely spaced signals at 15.6 and 16.0 ppm. When cystein 48 was replaced by the more bulky methionine, intense signals were observed at 13.8 and 14.0 ppm. Notably, the mutation in the N-terminal domain affects the entire spectrum rather than individual signals. Although a signal is consistently observed at about 8.8 ppm, at least its relative intensity is modulated substantially by the replacement of cystein 48.
###end p 32
###begin p 33
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rib5</italic>
###xml 53 55 53 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Oligonucleotide primers used for construction of rib5+ expression plasmid and for site-directed mutagenesis
###end p 33
###begin p 34
###xml 100 104 100 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rib5</italic>
###xml 104 105 104 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Oligonucleotides were designed to hybridize to the sense (+) and to the antisense (-) strand of the rib5+. Mutated bases are indicated in lower case. Codons specifying modified amino acid residues are shown in bold type. Novel restriction sites are underlined.
###end p 34
###begin p 35
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">19</sup>
###xml 124 134 124 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pombe. </italic>
###xml 0 134 0 134 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><sup>19</sup>F NMR spectra of 6-trifluoromethyl-7-oxo-8-ribityllumazine (Compound 7) in the presence of riboflavin synthase mutants of <italic>S. pombe. </italic></bold>
###xml 216 217 216 217 <bold xmlns:xlink="http://www.w3.org/1999/xlink">7</bold>
###xml 250 251 250 251 <bold xmlns:xlink="http://www.w3.org/1999/xlink">7</bold>
###xml 284 285 284 285 <bold xmlns:xlink="http://www.w3.org/1999/xlink">7</bold>
###xml 323 324 323 324 <bold xmlns:xlink="http://www.w3.org/1999/xlink">7</bold>
###xml 358 359 358 359 <bold xmlns:xlink="http://www.w3.org/1999/xlink">7</bold>
###xml 390 391 390 391 <bold xmlns:xlink="http://www.w3.org/1999/xlink">7</bold>
###xml 430 431 430 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 124 132 <span type="species:ncbi:4896">S. pombe</span>
19F NMR spectra of 6-trifluoromethyl-7-oxo-8-ribityllumazine (Compound 7) in the presence of riboflavin synthase mutants of S. pombe. Concentrations in the NMR samples were as follows: C48M, 0.28 mM protein, 1.10 mM 7; C48A, 0.15 mM protein, 0.57 mM 7; C48S, 0.15 mM protein, 0.80 mM 7; wild type, 0.28 mM protein, 1.22 mM 7; S146C, 0.20 mM protein, 0.92 mM 7; S146A, 0.26 mM protein, 1 mM 7. For other details see legend to Fig. 5.
###end p 35
###begin p 36
###xml 402 403 402 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
In the C-terminal domain, serine 146 is the topological equivalent of cystein 48. Although this residue appears to be absolutely conserved, its replacement by the less bulky alanine or the more bulky cystein has relatively little influence on the catalytic rate and the Michaelis constant of the enzyme. However, the replacement of serine 146 had major impact on the protein perturbation spectra (Fig. 7). The signal at 8.8 ppm which is present in the wild type protein and all cystein 48 mutants has an increased intensity in case of the S146A mutant but is absent or shifted in the S146C mutant protein. Again, it should be noted that the replacement of serine 146 affects the entire spectrum rather than individual signals.
###end p 36
###begin p 37
###xml 80 89 80 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pombe </italic>
###xml 396 398 396 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink">19</sup>
###xml 470 473 470 473 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6a </bold>
###xml 482 483 482 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 488 489 488 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 601 602 601 602 <bold xmlns:xlink="http://www.w3.org/1999/xlink">7</bold>
###xml 749 750 749 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 80 88 <span type="species:ncbi:4896">S. pombe</span>
In line with the other proteins described in this study, riboflavin synthase of S. pombe binds epimer A believed to represent the 7-R diasteromer, whereas epimer B (7-S) showed no detectable interaction (data not shown). The 6-trifluoromethyl groups of 6-trifluoromethyl-7-oxo-8-ribityl-lumazine and 6,7-bis(trifluoromethyl)-8-ribityllumazine hydrate (epimer A) are topologically equivalent. The 19F NMR signals assigned to that group in the bistrifluoromethyl compound 6a in Figs. 6 and 8 are spread out over a range of only about 4 ppm, as compared to a range of 9 ppm in case of the 7-oxo compound 7, but the impact of mutations is similar. Again, mutation of either cystein 48 or serine 146 affects all signals attributed to bound ligands (Fig. 8).
###end p 37
###begin p 38
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">19</sup>
###xml 144 154 144 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pombe. </italic>
###xml 2 154 2 154 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F NMR spectra of 6,7-bis(trifluoromethyl)-8-ribityllumazine hydrate (epimer A, Compound 6a) in the presence of riboflavin synthase mutants of <italic>S. pombe. </italic></bold>
###xml 236 238 236 238 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6a</bold>
###xml 271 273 271 273 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6a</bold>
###xml 306 308 306 308 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6a</bold>
###xml 346 348 346 348 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6a</bold>
###xml 382 384 382 384 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6a</bold>
###xml 415 419 415 419 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6a; </bold>
###xml 471 472 471 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 144 152 <span type="species:ncbi:4896">S. pombe</span>
19F NMR spectra of 6,7-bis(trifluoromethyl)-8-ribityllumazine hydrate (epimer A, Compound 6a) in the presence of riboflavin synthase mutants of S. pombe. Concentrations in the NMR samples were as follows: C48M, 0.30 mM protein, 0.94 mM 6a; C48A, 0.19 mM protein, 0.33 mM 6a; C48S, 0.20 mM protein, 0.42 mM 6a; wild type, 0.26 mM protein, 0.60 mM 6a; S146C, 0.26 mM protein, 0.65 mM 6a; S146A, 0.34 mM protein, 1 mM 6a; x, impurities. For other details see legend to Fig. 5.
###end p 38
###begin p 39
###xml 86 95 86 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pombe </italic>
###xml 212 213 212 213 <bold xmlns:xlink="http://www.w3.org/1999/xlink">9</bold>
###xml 220 221 220 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 86 94 <span type="species:ncbi:4896">S. pombe</span>
6,7-Bis(trifluoromethyl)-8-ribityllumazine hydrate (epimer A) could be displaced from S. pombe protein by addition of riboflavin or the product analog, 5-nitro-6-ribitylamino-2,4(1H,3H)-pyrimidinedione (Compound 9, Fig. 4), thus suggesting that each of the signals, assigned to bound ligand, represented binding sites with specificity for substrate/intermediate analogs rather than non-specific protein surface interactions (data not shown). In the mixture, epimer A displaced from the enzyme by the competing ligands had a linewidth of about 20 Hz.
###end p 39
###begin p 40
###xml 134 135 134 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10</xref>
###xml 330 332 330 332 <bold xmlns:xlink="http://www.w3.org/1999/xlink">7 </bold>
###xml 553 554 553 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
The complexity of the interaction of the proteins with the ligands is further illustrated by the titration experiments shown in Figs. 9 and 10. In the spectra of the wild type enzyme as well as the C48A mutant, the protein/ligand ratio affects not only the intensity and the line width of the different bands assigned to compound 7 in the protein bound state, but also the chemical shifts of individual signals. Remarkably, some of the peaks appeared with smaller line widths in later stages of the titration experiment (cf. peak at about 9 ppm in Fig. 9). This effect could indicate a combination of substrate induced conformational changes affecting the dynamics of the protein.
###end p 40
###begin p 41
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">19</sup>
###xml 127 136 127 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pombe </italic>
###xml 2 149 2 149 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F NMR spectra of 6-trifluoromethyl-7-oxo-8-ribityllumazine (Compound 7) in titration experiments with riboflavin synthase of <italic>S. pombe </italic>(wild type). </bold>
###xml 212 214 212 214 <bold xmlns:xlink="http://www.w3.org/1999/xlink">7 </bold>
###xml 388 389 388 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 127 135 <span type="species:ncbi:4896">S. pombe</span>
19F NMR spectra of 6-trifluoromethyl-7-oxo-8-ribityllumazine (Compound 7) in titration experiments with riboflavin synthase of S. pombe (wild type). The initial concentration of the protein was 0.36 mM. Compound 7 was added to the concentrations indicated. The spectra are displayed with equal intensities of the signals at 15.6 ppm (indicated by *). For other details see legend to Fig. 5.
###end p 41
###begin p 42
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">19</sup>
###xml 142 150 142 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pombe</italic>
###xml 2 152 2 152 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F NMR spectra of 6-trifluoromethyl-7-oxo-8-ribityllumazine (Compound 7) in titration experiments with C48A mutant of riboflavin synthase of <italic>S. pombe</italic>. </bold>
###xml 395 396 395 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 142 150 <span type="species:ncbi:4896">S. pombe</span>
19F NMR spectra of 6-trifluoromethyl-7-oxo-8-ribityllumazine (Compound 7) in titration experiments with C48A mutant of riboflavin synthase of S. pombe. The initial concentration of the protein was 0.24 mM. Compound 7 was added to the concentrations indicated in the spectra. The spectra are displayed with equal intensities of the signals as indicated by *. For other details see legend to Fig. 5.
###end p 42
###begin title 43
Discussion
###end title 43
###begin p 44
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 828 830 828 830 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6a</bold>
###xml 837 838 837 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 867 869 867 869 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6b</bold>
Lumazine proteins are paralogs of riboflavin synthase occurring in luminescent marine bacteria where they are believed to serve as optical transponders which absorb energy from bacterial luciferase by Forster transfer and are conducive to enhanced luminescence quantum yield as well as modulation of the emission frequency [28,29]. In contrast to the homotrimeric riboflavin synthase which can bind up to 6 substrate molecules, lumazine proteins have been reported to be monomers which bind only one molecule of 6,7-dimethyl-8-ribityllumazine. Although they are likely to share the two-domain architecture of the riboflavin synthase subunit, it appears that only one domain engages in ligand binding. Notably, all riboflavin synthases studied as well as lumazine protein are strictly stereoselective and bind epimer A (Compound 6a, Fig. 4) but not epimer B (Compound 6b) of the diastereomeric 6,7-bis(trifluoromethyl)-8-ribityllumazine hydrate.
###end p 44
###begin p 45
###xml 49 52 49 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6a </bold>
###xml 55 57 55 57 <bold xmlns:xlink="http://www.w3.org/1999/xlink">7 </bold>
###xml 97 99 97 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink">19</sup>
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 198 200 198 200 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 314 316 314 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink">19</sup>
###xml 385 387 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
Not surprisingly, when the fluorinated lumazines 6a or 7 are bound to lumazine protein, a single 19F NMR signal is observed for each respective trifluoromethyl group (Figs. 5A, 6A). Similarly, the c2 symmetric dimer obtained by recombinant expression of the N-terminal domain of riboflavin synthase shows a single 19F NMR signal for each trifluoromethyl group of a bound ligand (Figs. 5B, 6B).
###end p 45
###begin p 46
###xml 301 309 301 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C,5D,5E</xref>
###xml 311 319 311 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C,6D,6E</xref>
###xml 436 437 436 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
###xml 439 441 439 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10</xref>
###xml 643 645 643 645 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 721 729 721 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 737 739 737 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 721 728 <span type="species:ncbi:562">E. coli</span>
Since both domains of riboflavin synthase can bind ligand molecules, one would expect to observe separate sets of signals for ligands bound to each respective domain. Beyond that expectation, however, all riboflavin synthases studied in this paper show multiple signals for each ligand studied (Figs. 5C,5D,5E, 6C,6D,6E). Moreover, the signal patterns depend on the ratio of protein and ligand in the solution in unexpected ways (Figs. 9, 10), and the replacement of an amino acid at the C-terminal or N-terminal domain ligand binding site affects virtually all signals attributed to bound ligands. It follows that riboflavin synthase is not c3 symmetric in solution. The asymmetry revealed by the X-ray structure of the E. coli enzyme [15] is thus an inherent property of the enzyme and is not due to crystal contacts.
###end p 46
###begin p 47
###xml 136 138 136 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink">19</sup>
###xml 176 177 176 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 244 245 244 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 264 266 264 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink">19</sup>
Based on the NMR experiments with the mutant proteins obtained by replacement of cystein 48 or serine 146, it is now possible to assign 19F signals of the bound ligand in Fig. 7 to the N- or C-terminal domain. Comparison of the spectra in Fig. 7 suggests that the 19F signals shifted to lower field represent ligand molecules which are bound to the N-terminal domain and are therefore predominantly affected by the modification of cystein 48, whereas the signals shifted to higher field represent molecules bound to the C-terminal domain which are more susceptible to the modification of serine 146. However, it must be emphasized that all signals are affected at least to some extent by the mutations.
###end p 47
###begin p 48
###xml 27 35 27 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 455 457 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 458 460 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 27 34 <span type="species:ncbi:562">E. coli</span>
The X-ray structure of the E. coli enzyme suggests that direct contact exists only between the ligand binding sites of one N-terminal domain and the C-terminal domain of the adjacent subunit [15], whereas the ligand binding sites of two N-terminal and two C-terminal domains are exposed to solvent but not to an adjacent protein subunit. Since a number of studies has indicated that riboflavin synthase can bind certain ligands at a stoichiometry of 1:6 [18,20,22], we assume that each N-terminal and each C-terminal domain can participate in ligand binding.
###end p 48
###begin p 49
###xml 278 287 278 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pombe </italic>
###xml 608 616 608 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 731 740 731 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pombe </italic>
###xml 786 794 786 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 803 805 803 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 865 874 865 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pombe </italic>
###xml 875 877 875 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 278 286 <span type="species:ncbi:4896">S. pombe</span>
###xml 608 615 <span type="species:ncbi:562">E. coli</span>
###xml 731 739 <span type="species:ncbi:4896">S. pombe</span>
###xml 786 793 <span type="species:ncbi:562">E. coli</span>
###xml 865 873 <span type="species:ncbi:4896">S. pombe</span>
The major difference is a cysteine residue (position 48 in the N-terminal domain) being replaced by a serine residue (position 146 in the C-terminal domain). Both amino acids are absolutely conserved in all putative riboflavin synthase paralogs. Nevertheless, serine 146 of the S. pombe enzyme can be replaced by alanine with only a minor impact on enzyme activity. Replacement of cysteine 48 by serine reduces the activity by a factor of five, but replacement by alanine affords a soluble protein whose activity, if any, is below the level of detection. It should also be noted that mutant genes specifying E. coli riboflavin synthase mutants carrying alanine or serine instead of cysteine 48 (corresponding to cysteine 48 of the S. pombe enzyme) could not be expressed in recombinant E. coli strains [18]. As seen in the X-ray structure of riboflavin synthase of S. pombe [21] the closest neighbor of the thiol group at position 48 is the 6-methylene group of the substrate analog, 6-carboxyethyl-7-oxo-8-ribityllumazine with a distance of 3.7 Adegrees indicating an essential role of C48 in the catalytic mechanism of riboflavin synthase.
###end p 49
###begin p 50
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 237 245 237 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 269 271 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 280 289 280 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pombe </italic>
###xml 324 333 324 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pombe </italic>
###xml 521 523 517 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 237 244 <span type="species:ncbi:562">E. coli</span>
###xml 280 288 <span type="species:ncbi:4896">S. pombe</span>
###xml 324 332 <span type="species:ncbi:4896">S. pombe</span>
The riboflavin synthase subunit folds into two domains with closely similar folding topology. This had been anticipated on the basis of sequence arguments [14] and has been confirmed by X-ray structure analysis of riboflavin synthase of E. coli (without bound ligand) [15] and of S. pombe (with bound ligand). The monomeric S. pombe riboflavin synthase model arranged in a distinct N-terminal barrel (residues 1-90), an almost identically folded distinc C-terminal barrel (residues 91-184), and a C-terminal alpha-helix [21].
###end p 50
###begin p 51
###xml 322 324 322 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink">19</sup>
###xml 420 431 420 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vice versa </italic>
On basis of these structural arguments, one could expect that ligands bound to C-terminal domains without close interaction with N-terminal domains should not be influenced by conservative changes in the N-terminal domain. More specifically, the replacement of sulfur by oxygen in the C48S mutant should not influence the 19F resonance of ligands bound at topologically remote C-terminal domain. The same argument holds vice versa for the influence of mutations in the C-terminal domain, e.g. the replacement of oxygen by sulfur in the C-terminal domain on ligands bound to distant N-terminal domains.
###end p 51
###begin p 52
###xml 160 162 160 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink">19</sup>
###xml 659 661 659 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 822 824 822 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 925 933 925 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 925 932 <span type="species:ncbi:562">E. coli</span>
On basis of the finding that, contrary to that hypothesis, minor modifications of either N-terminal or C-terminal binding sites can modulate all aspects of the 19F signatures of the bound ligands, we propose that riboflavin synthase is subject to large scale dynamic motions occurring on the time scale of the NMR experiments. More specifically, we propose that the pair of N-terminal and C-terminal domain in direct contact as observed in the crystal structure is not permanently associated in solution where the respective domains of different subunits can temporarily assume that special relationship by major domain motions. Previous structural analysis [15] and molecular modeling revealed a markedly nonsymmetric trimeric state of riboflavin synthase. The modeling experiments, based on the inhibitor-bound protein [21], strongly suggest that the close intersubunit contact of the trimer as seen in the crystals of the E. coli protein is indeed in an active conformation and capable of supporting the dismutation reaction. Therefore, this trimer very likely represents a distinct functional state. As there is no reason to suggest a static asymmetric ensemble, it appears likely that thermal fluctuation or substrate binding converts the three different intersubunit contacts into one another, retaining an asymmetric trimer.
###end p 52
###begin p 53
###xml 154 156 154 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink">19</sup>
###xml 237 238 237 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
###xml 243 245 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F10">10</xref>
Such a dynamic model would fit the wide variation of line widths found for the different protein bound states as well as the unexpected dependence of the 19F NMR spectra on the molar ratio between protein and ligand as revealed in Figs. 9 and 10.
###end p 53
###begin title 54
Conclusions
###end title 54
###begin p 55
The observations on protein dynamics are highly relevant for the reaction mechanism. Conceivably, the ligand binding sites of N- and C-terminal domains can be loaded with substrate while they are out of physical contact with each other. In order for the dismutation to occur, the domains could then form the local N-terminal/C-terminal domain complex by motion of the entire protein. The products could be unloaded after that domain pair has been separated again by major protein motions, and contacts between other domains could be established which could also result in product formation. In other words, all six domains would participate in the dismutation of the substrate, but they would do so at different times.
###end p 55
###begin p 56
###xml 178 180 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 293 302 293 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pombe </italic>
###xml 318 321 318 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1 </sup>
###xml 293 301 <span type="species:ncbi:4896">S. pombe</span>
A dynamic model involving configuration changes of riboflavin synthase in the context of the catalytic reaction has been proposed earlier on basis of competitive ligand binding [23]. Since the reaction catalyzed by riboflavin synthase occurs on the time of seconds (the turnover number of the S. pombe enzyme is 11 min-1 per trimer), relatively slow dynamic motions occurring on the millisecond time scale would amply suffice the dynamic requirements of that slow catalytic reaction.
###end p 56
###begin title 57
Methods
###end title 57
###begin title 58
Materials
###end title 58
###begin p 59
###xml 32 34 32 34 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 80 82 80 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 126 128 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 207 209 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
6,7-Dimethyl-8-ribityllumazine [30], 6-trifluoromethyl-7-oxo-8-ribityllumazine [19], 6-carboxy-ethyl-7-oxo-8-ribityllumazine [31,32] and 6,7-bis(trifluoromethyl)-8-ribityllumazine hydrate (epimers A and B) [19] were prepared by published procedures. Oligonucleotides were custom synthesized by Interactiva, Ulm, Germany. Restriction enzymes were from New England Biolabs, Schwalbach, Germany. T4 DNA ligase and reverse transcriptase (SuperScriptII) were from Gibco BRL, Eggenstein, Germany. Taq Polymerase was from Finnzyme, Epsoo, Finnland. Vent DNA po-lymerase was purchased by New England Biolabs, Schwalbach, Germany. DNA fragments were purified with the QIAquick PCR Purification Kit from Qiagen, Hilden, Germany.
###end p 59
###begin title 60
Microorganisms and plasmids
###end title 60
###begin p 61
###xml 71 72 71 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
Microorganisms and plasmids used in this study are summarized in Table 1.
###end p 61
###begin title 62
Proteins
###end title 62
###begin p 63
###xml 35 43 35 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 47 59 47 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B. subtilis </italic>
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 98 100 98 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 35 42 <span type="species:ncbi:562">E. coli</span>
###xml 47 58 <span type="species:ncbi:1423">B. subtilis</span>
Recombinant riboflavin synthase of E. coli and B. subtilis were prepared as described earlier [18,23].
###end p 63
###begin title 64
Preparation of cDNA
###end title 64
###begin p 65
###xml 26 46 26 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pombe var. pombe </italic>
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 26 34 <span type="species:ncbi:4896">S. pombe</span>
The isolation of RNA from S. pombe var. pombe Lindner (ATCC 16491) and the preparation of cDNA was performed as described earlier [33].
###end p 65
###begin title 66
###xml 20 26 20 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rib5+ </italic>
Construction of the rib5+ expression plasmid
###end title 66
###begin p 67
###xml 87 96 87 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. pombe </italic>
###xml 171 172 171 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 220 224 220 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EcoR</italic>
###xml 230 234 230 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BamH</italic>
###xml 365 382 365 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pNCO-SSP-Rosy-WT.</italic>
###xml 87 95 <span type="species:ncbi:4896">S. pombe</span>
A hypothetical open reading frame (accession number T40995) was amplified by PCR using S. pombe cDNA as template and the oligonucleotides SSP-RIB5-1 and SSP-RIB5-2 (Table 2) as primers. The amplificate was digested with EcoRI and BamHI and was ligated into the expression vector pNCO113 which had been digested with the same enzymes yielding the plasmid designated pNCO-SSP-Rosy-WT.
###end p 67
###begin p 68
Steady state kinetic analysis of wild type and mutant riboflavin synthases
###end p 68
###begin title 69
Site directed mutagenesis
###end title 69
###begin p 70
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 83 100 83 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pNCO-SSP-Rosy-WT </italic>
###xml 174 175 174 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
A procedure described earlier was used for site-directed mutagenesis [18]. Plasmid pNCO-SSP-Rosy-WT was used as template. The primers used for mutagenesis are shown in Table 2.
###end p 70
###begin title 71
###xml 18 26 18 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 18 25 <span type="species:ncbi:562">E. coli</span>
Transformation of E. coli cells
###end title 71
###begin p 72
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 262 264 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 0 7 <span type="species:ncbi:562">E. coli</span>
E. coli XL-1 Blue cells were transformed with ligation mixtures by published procedures [34]. Transformants were selected on LB agar plates supplemented with ampicillin (170 mg/l). All plasmid constructs were sequenced by the automated dideoxynucleotide method [35] using a 377 Prism DNA sequencer from Applied Biosystems (Weiterstadt, Germany).
###end p 72
###begin p 73
###xml 76 84 76 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 170 174 170 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lac </italic>
###xml 427 431 427 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lac </italic>
###xml 76 83 <span type="species:ncbi:562">E. coli</span>
pNCO113 type plasmids reisolated from XL-1 Blue cells were transformed into E. coli M15 [pREP4] [36] cells carrying the pREP4 repressor plasmid for the overexpression of lac repressor protein. Kanamycin (15 mg/l) and ampicillin (170 mg/l) were added to secure the maintenance of both plasmids in the host strain. In the pNCO113 expression plasmids, the riboflavin synthase variants are under control of the T5 promotor and the lac operator.
###end p 73
###begin p 74
###xml 74 82 74 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 173 177 173 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lac </italic>
###xml 74 86 <span type="species:ncbi:511693">E. coli BL21</span>
###xml 88 91 <span type="species:ncbi:511693">DE3</span>
pT7-7 type plasmids reisolated from XL-1 Blue cells were transformed into E. coli BL21 (DE3) cells. The host strain contains a T7 RNA polymerase gene under the control of a lac operator, whereas the riboflavin synthase genes are under control of the T7 promotor.
###end p 74
###begin title 75
Protein purification
###end title 75
###begin p 76
###xml 12 20 12 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 829 831 805 807 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 1269 1271 1245 1247 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 1531 1533 1507 1509 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 12 19 <span type="species:ncbi:562">E. coli</span>
Recombinant E. coli strains were grown in LB medium containing ampicillin (170 mg/l) and kana-mycin (20 mg/l) at 37degreesC with shaking overnight. Erlenmeyer flasks containing 500 ml of medium were inoculated at a ratio of 1:50 and were incubated at 37degreesC with shaking. At an optical density of 0.6 (600 nm), IPTG was added to a final concentration of 2 mM, and incubation was continued for 5 h. The cells were harvested by centrifugation, washed with 0.9 % NaCl and stored at -20degreesC. Frozen cell mass (6 g) was thawed in 35 ml of 20 mM potassium phosphate, pH 7.0. The suspension was subjected to ultrasonic treatment and was then centrifuged (20 min, 15,000 rpm, 4degreesC). The supernatant was placed on top of a Q-Sepharose column (2.0 x 7.5 cm, Amersham Phar-macia Biotech, Freiburg, Germany) (flow rate, 5 ml min-1) which had been equilibrated with 200 mM potassium phosphate, pH 7.0. The column was developed with a linear gradient of 0-1.0 M potassium chloride in 20 mM potassium phosphate, pH 7.0 (total volume, 700 ml). Fractions were combined and concentrated by ultrafiltration using Amicon 10 kDa membranes. The solution was placed on top of a Superdex-200 column (2.6 x 60 cm, Amersham Pharmacia Biotech, Freiburg, Germany) (flow rate, 3 ml min-1) which was developed with 20 mM potassium phosphate, pH 7.0, containing 70 mM potassium chloride. Fractions were combined and placed on top of a column of Phenyl-Sepharose CL4B (1.5 x 5.5 cm, Amersham Pharmacia Biotech, Freiburg, Germany) (flow rate, 2 ml min-1) which had been equilibrated with 20 mM potassium phosphate, pH 7.0, containing 500 mM ammonium sulfate. The column was developed with a linear gradient of 0-10 % glycerol containing 20 mM potassium phosphate, pH 7.0 (total volume, 100 ml).
###end p 76
###begin title 77
Isolation and purification of lumazine protein
###end title 77
###begin p 78
###xml 52 60 52 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 365 367 365 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 934 936 934 936 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 52 59 <span type="species:ncbi:562">E. coli</span>
###xml 72 75 <span type="species:ncbi:511693">DE3</span>
Inclusion bodies were isolated from the recombinant E. coli strain BL21(DE3) [pPHL36] and were solubilized as described earlier [37]. A solution (25 ml) containing 50 mM Tris hydrochloride, pH 7.2, 0.5 mM DTT and solubilized protein was passed through a column of Q Sepharose Fast Flow (2 x 18 cm, Amersham Pharmacia Biotech, Freiburg, Germany) (flow rate, 1 ml min-1). The column was washed with 100 ml of 50 mM Tris hydrochloride, pH 7.2, containing 0.5 mM DTT and was then developed with a linear gradient of 0 - 0.5 M NaCl in the same buffer (total volume, 280 ml). Lumazine protein was eluted from 220 to 260 ml. The enzyme fraction was dialyzed against 50 mM sodium/potassium phosphate, pH 7.0, containing 5 mM 2-mercaptoethanol. The solution was centrifuged for 30 min at 26,000x g, and the supernatant was passed through a column of Superdex 75 (2.6 x 60 cm, Amersham Pharmacia Biotech, Freiburg, Germany) (flow rate, 3 ml min-1). The column was developed with 360 ml of 50 mM phosphate, pH 7.0, containing 5 mM DTT. The enzyme was eluted from 180 to 200 ml. Fractions were combined and concentrated by ultrafiltration.
###end p 78
###begin title 79
Estimation of protein concentration
###end title 79
###begin p 80
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
Protein concentration was estimated by a modified Bradford procedure [38].
###end p 80
###begin title 81
SDS polyacrylamide gel electrophoresis
###end title 81
###begin p 82
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
Sodium dodecyl sulfate polyacrylamide gel electrophoresis was performed with 16 % polyacryl-amide gels by published procedures [39]. Molecular weight standards were supplied by Sigma (Munich, Germany).
###end p 82
###begin title 83
Protein sequencing
###end title 83
###begin p 84
Sequence determination was performed by the automated Edman method using a 471 A Protein Sequencer (Perkin Elmer).
###end p 84
###begin title 85
Steady state kinetics
###end title 85
###begin p 86
###xml 284 287 278 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1 </sup>
###xml 289 292 283 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1 </sup>
###xml 303 304 297 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 305 307 299 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
Assay mixtures containing 100 mM phosphate, pH 7.2, 10 mM EDTA, 10 mM sodium sulfite, 0.6 mM 6,7-dimethyl-8-ribityllumazine, and protein were incubated at 37degreesC. Formation of riboflavin was monitored photometrically at 470 nm. The absorbance coefficient for riboflavin is 9,100 M-1 cm-1 at 470 nm [7,40].
###end p 86
###begin title 87
Analytical ultracentrifugation
###end title 87
###begin p 88
###xml 517 520 517 520 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1 </sup>
###xml 521 523 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 690 692 690 692 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 882 884 876 878 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
Boundary sedimentation and sedimentation equilibrium experiments were performed using an analytical ultracentrifuge Optima XL-I from Beckman Instruments (Palo Alto, CA) equipped with absorbance and interference optics. Aluminum double sector cells equipped with sapphire windows were used throughout. Protein solutions were dialyzed against 20 mM potassium phosphate, pH 7.0, containing 100 mM potassium chloride. The partial specific volume was estimated from the amino acid composition yielding a value of 0.73 ml g-1 [41]. Sedimentation equilibrium experiments were performed with a solution containing 20 mM potassium phosphate, pH 7.0, 100 mM potassium chloride, and protein (0.7 mg ml-1). Samples were centrifuged at 11,000 rpm and 4degreesC for 72 h. Protein concentration was monitored photometrically at 280 nm. For boundary sedimentation experiments the protein (1.6 mg ml-1) was centrifuged at 55,000 rpm and 20degreesC for 2 h. Protein concentration was monitored interferometrically at intervals of 10 min.
###end p 88
###begin title 89
Electrospray mass spectrometry
###end title 89
###begin p 90
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
Experiments were performed with a triple quadrupol ion spray mass spectrometer API365 (SciEx, Thornhill, Ontario, Canada) [42].
###end p 90
###begin title 91
NMR spectroscopy
###end title 91
###begin p 92
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">19</sup>
###xml 139 141 139 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink">19</sup>
###xml 522 523 509 510 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
19F NMR spectra were recorded at 470 MHz using an AVANCE 500 MHz spectrometer from Bruker Instruments (Karlsruhe, Germany) equipped with a 19F probehead. Experimental parameters were as follows: pulse angle, 70degrees (10 musec); repetition rate, 3 sec; 64 K data set; 500 to 20,000 scans. Chemical shifts were referenced to an external standard containing 50 mM sodium trifluoroacetate, pH 7.0. Measurements were performed at 11 degreesC. Samples contained 20 mM phosphate, pH 7.0, and 100 mM potassium chloride in 10 % D2O.
###end p 92
###begin title 93
Authors contributions
###end title 93
###begin p 94
The study was designed and coordinated by MF and AB. The study was performed as follows: AKS, BI, KK, MF, WE contributed to the NMR part of the manuscript. MF cloned and overexpressed the protein. RF, AKS purified the protein. MC synthezised the ligands used in this study. BI constructed the mutant proteins. SS, SG, RH, GR participated in the discussion of the study.
###end p 94
###begin title 95
Acknowledgements
###end title 95
###begin p 96
This work was supported by grants from the Deutsche Forschungsgemeinschaft and the Fonds der Chemischen Industrie. We thank Angelika Werner for expert help with the preparation of the manuscript, Peter Kohler for protein sequencing, Lars Schulte for skillful assistance and Adolphus van Loon for plasmids. Mark Cushman is grateful for the support afforded by NIH Grant GM51469.
###end p 96
###begin article-title 97
###xml 25 41 <span type="species:ncbi:562">Escherichia coli</span>
Riboflavin auxotrophs of Escherichia coli
###end article-title 97
###begin article-title 98
###xml 22 24 22 24 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 70 92 70 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Salmonella typhimurium</italic>
###xml 70 92 <span type="species:ncbi:90371">Salmonella typhimurium</span>
Isolation of vitamin B2 auxotrophs and preliminary genetic mapping in Salmonella typhimurium
###end article-title 98
###begin article-title 99
###xml 45 69 45 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 45 69 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Isolation of riboflavin-deficient mutants of Saccharomyces cerevisiae
###end article-title 99
###begin article-title 100
###xml 62 84 62 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pichia guilliermondii </italic>
###xml 62 83 <span type="species:ncbi:4929">Pichia guilliermondii</span>
###xml 94 100 <span type="species:ncbi:4932">yeasts</span>
Preparation and properties of riboflavin-dependent mutants of Pichia guilliermondii Wickerham yeasts
###end article-title 100
###begin article-title 101
Studies on the nature of the enzymic conversion of 6,7-dimethyl-8-ribityllumazine to riboflavin
###end article-title 101
###begin article-title 102
###xml 25 30 <span type="species:ncbi:4932">yeast</span>
Riboflavin synthase from yeast: Properties of complexes of the enzyme with lumazine derivatives and riboflavin
###end article-title 102
###begin article-title 103
Studies on the mechanism of elimination of protons from the methyl groups of 6,7-dimethyl-6-ribityllumazine by riboflavin synthetase
###end article-title 103
###begin article-title 104
Stereospecificity of the enzymic synthesis of the o-xylene ring of riboflavin
###end article-title 104
###begin article-title 105
Deuterium exchange of C-methyl protons in 6,7-dimethyl-8-D-ribityllumazine, and studies of the mechanism of riboflavin biosynthesis
###end article-title 105
###begin article-title 106
###xml 68 70 68 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink">13</sup>
Enzymatic synthesis of riboflavin and FMN specifically labeled with 13C in the xylene ring
###end article-title 106
###begin article-title 107
A pentacyclic reaction intermediate of riboflavin synthase
###end article-title 107
###begin article-title 108
###xml 24 41 24 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bacillus subtilis</italic>
###xml 24 41 <span type="species:ncbi:1423">Bacillus subtilis</span>
Riboflavin synthases of Bacillus subtilis. Purification and properties
###end article-title 108
###begin article-title 109
###xml 100 117 100 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli.</italic>
###xml 100 116 <span type="species:ncbi:562">Escherichia coli</span>
Cloning, sequencing, mapping and hyperexpression of the ribC gene coding for riboflavin synthase of Escherichia coli.
###end article-title 109
###begin article-title 110
###xml 24 41 24 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bacillus subtilis</italic>
###xml 24 41 <span type="species:ncbi:1423">Bacillus subtilis</span>
Riboflavin synthases of Bacillus subtilis. Purification and amino acid sequence of the alpha subunit
###end article-title 110
###begin article-title 111
Crystal structure of riboflavin synthase
###end article-title 111
###begin article-title 112
Domain structure of riboflavin synthase
###end article-title 112
###begin article-title 113
The solution structure of the N-terminal domain of riboflavin synthase
###end article-title 113
###begin article-title 114
###xml 23 39 <span type="species:ncbi:562">Escherichia coli</span>
Riboflavin synthase of Escherichia coli. Effect of single amino acid substitutions on reaction rate and ligand binding properties
###end article-title 114
###begin article-title 115
###xml 141 159 141 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bacillus subtilis.</italic>
###xml 141 158 <span type="species:ncbi:1423">Bacillus subtilis</span>
Synthesis of epimeric 6,7-bis(trifluoromethyl)-8-ribityllumazine hydrates. Stereoselective interaction with the light riboflavin synthase of Bacillus subtilis.
###end article-title 115
###begin article-title 116
F NMR Studies on the mechanism of riboflavin synthase. Synthesis of 6-(Trifluoromethyl)-7-oxo-8-(D-ribityl)lumazine and 6-(Trifluoromethyl)-7-methyl-8-(D-ribityl)lumazine
###end article-title 116
###begin article-title 117
Studies on the reaction mechanism of riboflavin synthase. X-ray crystal structure of a complex with 6-carboxyethyl-7-oxo-8-ribityllumazine
###end article-title 117
###begin article-title 118
###xml 57 75 57 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bacillus subtilis.</italic>
###xml 57 74 <span type="species:ncbi:1423">Bacillus subtilis</span>
Ligand-binding studies on light riboflavin synthase from Bacillus subtilis.
###end article-title 118
###begin article-title 119
NMR analysis of site-specific binding in oligomeric proteins. Dynamic studies on the interaction of riboflavin synthase with trifluoromethyl-substituted intermediates
###end article-title 119
###begin article-title 120
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">19</sup>
###xml 41 68 41 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Photobacterium phosphoreum.</italic>
###xml 41 67 <span type="species:ncbi:659">Photobacterium phosphoreum</span>
19F NMR studies on lumazine protein from Photobacterium phosphoreum.
###end article-title 120
###begin article-title 121
###xml 39 41 39 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink">19</sup>
Trifluoromethyllumazine derivatives as 19F NMR probes for lumazine protein
###end article-title 121
###begin article-title 122
###xml 92 94 92 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink">15</sup>
###xml 96 98 96 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink">19</sup>
Investigation of the binding of fluorolumazines to the 1-MDa capsid of lumazine synthase by 15N{19F} REDOR NMR
###end article-title 122
###begin article-title 123
###xml 135 153 135 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bacillus subtilis </italic>
###xml 181 183 181 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink">15</sup>
###xml 185 187 185 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink">19</sup>
###xml 135 152 <span type="species:ncbi:1423">Bacillus subtilis</span>
Investigation of the binding of epimer A of the covalent hydrate of 6,7-bis(trifluoromethyl)-8-D-ribityllumazine to a recombinant F22W Bacillus subtilis lumazine synthase mutant by 15N{19F}REDOR NMR
###end article-title 123
###begin article-title 124
Separation of a blue fluorescence protein from bacterial luciferase
###end article-title 124
###begin article-title 125
###xml 52 67 52 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Photobacterium.</italic>
Physical characterization of lumazine proteins from Photobacterium.
###end article-title 125
###begin article-title 126
Enzymatic synthesis of 6,7-dimethyl-8-ribityllumazine
###end article-title 126
###begin article-title 127
Specific enzyme inhibitors in vitamin biosynthesis. II. Revised structures for some 8-substituted pyrido(2,3-d)-pyrimidines
###end article-title 127
###begin article-title 128
Specific enzyme inhibitors in vitamin biosynthesis. Part 3. The synthesis and inhibitory properties of some substrate and transition state analogs of riboflavin synthase
###end article-title 128
###begin article-title 129
###xml 71 96 71 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Schizosaccharomyces pombe</italic>
###xml 71 96 <span type="species:ncbi:4896">Schizosaccharomyces pombe</span>
Biosynthesis of Riboflavin. 6,7-Dimethyl-8-ribityllumazine synthase of Schizosaccharomyces pombe
###end article-title 129
###begin article-title 130
###xml 54 71 54 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 54 70 <span type="species:ncbi:562">Escherichia coli</span>
XL1-blue: a high efficiency plasmid transforming recA Escherichia coli strain with beta-galactosidase selection
###end article-title 130
###begin article-title 131
DNA sequencing with chain-terminating inhibitors
###end article-title 131
###begin article-title 132
###xml 36 53 36 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 36 52 <span type="species:ncbi:562">Escherichia coli</span>
System for high-level production in Escherichia coli and rapid purification of recombinant proteins: application to epitop mapping, preparation of antibodies, and structure-function analysis
###end article-title 132
###begin article-title 133
###xml 80 105 80 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Photobacterium leiognathi</italic>
###xml 80 105 <span type="species:ncbi:553611">Photobacterium leiognathi</span>
Expression and properties of the recombinant lumazine (riboflavin) protein from Photobacterium leiognathi
###end article-title 133
###begin article-title 134
Minimization of variation in the response to different proteins of the Coomassie blue G dye-binding assay for protein
###end article-title 134
###begin article-title 135
###xml 67 83 <span type="species:ncbi:10665">bacteriophage T4</span>
Cleavage of structural proteins during the assembly of the head of bacteriophage T4
###end article-title 135
###begin article-title 136
The enzymic synthesis of riboflavin
###end article-title 136
###begin article-title 137
electrospray mass spectrometry for protein characterization
###end article-title 137
###begin article-title 138
###xml 31 48 31 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 31 47 <span type="species:ncbi:562">Escherichia coli</span>
Construction and properties of Escherichia coli strains exhibiting alpha-complementation of beta-galactosidase fragments in vivo
###end article-title 138
###begin article-title 139
###xml 7 23 <span type="species:ncbi:10760">bacteriophage T7</span>
Use of bacteriophage T7 lysozyme to improve an inducible T7 expression system
###end article-title 139
###begin article-title 140
Expression using the T7 RNA polymerase/promoter system
###end article-title 140

